Rennova Health, Inc.
Rennova Health, Inc. Fundamental Analysis
Rennova Health, Inc. (RNVA) shows moderate financial fundamentals with a PE ratio of -0.42, profit margin of -41.36%, and ROE of 23.45%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 16.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze RNVA's fundamental strength across five key dimensions:
Efficiency Score
WeakRNVA struggles to generate sufficient returns from assets.
Valuation Score
ExcellentRNVA trades at attractive valuation levels.
Growth Score
ModerateRNVA shows steady but slowing expansion.
Financial Health Score
ModerateRNVA shows balanced financial health with some risks.
Profitability Score
ModerateRNVA maintains healthy but balanced margins.
Key Financial Metrics
Is RNVA Expensive or Cheap?
P/E Ratio
RNVA trades at -0.42 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, RNVA's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Rennova Health, Inc. at -0.09 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -5.12 times EBITDA. This is generally considered low.
How Well Does RNVA Make Money?
Net Profit Margin
For every $100 in sales, Rennova Health, Inc. keeps $-41.36 as profit after all expenses.
Operating Margin
Core operations generate 7.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $23.45 in profit for every $100 of shareholder equity.
ROA
Rennova Health, Inc. generates $-38.16 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Rennova Health, Inc. produces operating cash flow of $4.44M, showing steady but balanced cash generation.
Free Cash Flow
Rennova Health, Inc. generates strong free cash flow of $3.98M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
RNVA converts 70.54% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.42
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.09
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.23
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.32
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.16
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.23
vs 25 benchmark
ROA
Return on assets percentage
-0.38
vs 25 benchmark
ROCE
Return on capital employed
-0.06
vs 25 benchmark
How RNVA Stacks Against Its Sector Peers
| Metric | RNVA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.42 | 28.45 | Better (Cheaper) |
| ROE | 23.45% | 763.00% | Weak |
| Net Margin | -41.36% | -45265.00% (disorted) | Weak |
| Debt/Equity | -0.32 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 0.16 | 2795.60 | Weak Liquidity |
| ROA | -38.16% | -16588.00% (disorted) | Weak |
RNVA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Rennova Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation